Empagliflozin in Hypertrophic Cardiomyopathy
Empagliflozin in Hypertrophic Cardiomyopathy
Active, not recruiting · NCT05182658 · Registry updated 2026-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin in Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart failure, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Active, not recruiting | Phase 3 | 2026-03-12 | NCT05182658 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amsterdam UMC, location VUmc | 102 |
| Medical University of Bialystok | 22 |
| National Institute of Cardiology, Warsaw, Poland | 14 |
| University of Eastern Finland | 44 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of Bialystok | Bialystok | Poland | 2 |
| National Institute of Cardiology | Warsaw | Poland | 6 |